A Glimpse Into The Expert Outlook On Apellis Pharmaceuticals Through 20 Analysts
A Glimpse Into The Expert Outlook On Apellis Pharmaceuticals Through 20 Analysts
通过20位分析师对apellis pharmaceuticals的专家展望的简要介绍
A comprehensive examination...Providing a diverse range of perspectives from bullish to bearish, 20 analysts have published ratings on Apellis Pharmaceuticals (NASDAQ:APLS) in the last three months.
在过去三个月中，有20位分析师就Apellis Pharmaceuticals (纳斯达克股票代码：APLS) 发布了从看好到看淡的多元化观点。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级概况，突出了过去30天内情绪的变化，并将其与之前的月份进行了比较。
Analysts have set 12-month price targets for Apellis Pharmaceuticals, revealing an average target of $45.35, a high estimate of $92.00, and a low estimate of $24.00. A 23.06% drop is evident in the current average compared to the previous average price target of $58.94.
分析师为Apellis Pharmaceuticals设定了12个月的价格目标，显示平均目标为45.35美元，最高估值为92.00美元，最低估值为24.00美元。与先前的平均目标价格58.94美元相比，当前平均价格下跌了23.06%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探讨分析师评级：分析师评级的深度探讨
A comprehensive examination...
最近分...
登录免费看全文
登录/注册
资讯热榜
更新时间